https://www.lyntonix.com/custom_137505.html舒藤新藥找到新的腸躁症作用機轉舒藤新藥找到新的腸躁症作用機轉
Chang, W.-Y., Yang, Y.-T., She, M.-P., Tu, C.-H., Lee, T.-C., Wu, M.-S., Sun, C.-H., Hsin, L.-W., & Yu, L. C.-H. (2022). 5-HT7 receptor-dependent intestinal neurite outgrowth contributes to visceral hypersensitivity in irritable bowel syndrome. Laboratory Investigation, 102(9), 1023-1037. https://doi.org/10.1038/s41374-022-00800-z
She, M. P., Hsieh, Y. T., Lin, L. Y., Tu, C. H., Wu, M. S., Hsin, L. W., & Yu, L. C. (2024). Differential roles of serotonin receptor subtypes in regulation of neurotrophin receptor expression and intestinal hypernociception. Histol Histopathol, 39(7), 903-919. https://doi.org/10.14670/hh-18-687
Lee, T. Y., Lin, Y. H., Chang, W. Y., Lin, L. Y., Chang, C. F., Kuo, W. T., Tu, C. H., Wu, M. S., Hsin, L. W., & Yu, L. C. (2025). 5-HT(7) antagonists confer analgesia via suppression of neurotrophin overproduction in submucosal nerves of mouse models with visceral hypersensitivity. The Journal of Physiology, 603(17), 4723-4745. https://doi.org/https://doi.org/10.1113/JP286444
https://www.lyntonix.com/custom_137506.html舒藤新藥擁有全球多國專利舒藤新藥擁有全球多國專利8-PHENYLISOQUINOLINES AND PHARMACEUTICAL COMPOSITION THERE OF USED IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME (點擊獲得更多資訊)
日本專利：JP6920759 (B2)，2021/08/18~2038/03/02
韓國專利：KR102296368 (B1)，2021/09/01~2038/03/02
美國專利：US11505529 (B2)，2022/11/22~2039/11/04
歐盟專利：EP3589626 (B1)，2024/06/12~2038/03/02， 英國、德國、法國、瑞士、義大利取證
中華民國專利：TWI648265 (B)，2019/01/21~2038/03/02
中國專利：CN110475773 (A)，2025/05/01~2038/03/02
